These consultations can provide legal options about whether such families may be eligible to seek compensation for medical costs, pain and suffering and other expenses that may stem from these circumstances.
SSRI anti-depressants are the newest class of anti-depressants and are sold under various brand and generic drug names such as Zoloft, Prozac, Paxil, Lexapro and Depakote. The National Institute of Mental Health describes these medications as the most popular type of anti-depressants.**
The common allegations in the Zoloft multidistrict litigation* are that women who used Zoloft to treat depression while pregnant were put at increased risk of giving birth to an infant suffering from birth defects such as cleft palate, club foot, spina bifida and heart and abdominal defects, according to the claims in the court files.
Also claimed in these court filings are allegations that some infants may have been born suffering from the life-threatening condition known as pulmonary hypertension in newborns (PPHN).
This condition, according to the Food and Drug Administration, occurs when a newborn baby does not adapt to breathing outside the womb.**
The FDA says that newborns with PPHN may require intensive care support including a mechanical ventilator to increase their oxygen level. If severe, PPHN can result in multiple organ damage, including brain damage, and even death.
Resource4thePeople notes that the FDA has given mixed signals about the link between PPHN and SSRI use. In 2006 the agency issued a warning about the dangers of SSRI use and PPHN. Now the FDA says it is unsure.***
Here is the most recent statement by the FDA, released on Dec. 14, 2011:
“The U.S. Food and Drug Administration (FDA) is updating the public on the use of selective serotonin reuptake inhibitor (SSRI) antidepressants by women during pregnancy and the po
Copyright©2012 Vocus, Inc.
All rights reserved